Moreover, multivariate regression analysis further confirmed that S100A2 expression was an independent prognostic factor for OS in patients with endometrial carcinoma (HR = 1.635, 95% CI = 1.005-2.659, P = 0.048) (Table 3; Fig. 5). This evidence concerns the gene S100A2 and endometrial carcinoma.